Optimizing Mobility and Cognitive Function

Post-stroke rehabilitation aims to restore mobility and cognitive abilities often impaired after a stroke. Stem cell and exosome therapy is recognized as a promising approach to enhance recovery, even for patients with ischemic, hemorrhagic, or transient ischemic attack (TIA) events, years after the initial incident.

CRC has a proven track record in treating stroke patients, supported by over 5,000 published papers on stem cell treatment for strokes. This therapy promotes neural repair and regeneration by utilizing stem cells that differentiate into various cell types and release growth factors to support healing in the brain.

The treatment protocol combines two routes of administration: intrathecal injections into the spinal fluid and intravenous (IV) delivery into the bloodstream, ensuring comprehensive targeting of affected areas. Most patients experience noticeable improvements within 2 to 4 months, particularly in mobility and cognitive function.

While many symptoms respond favorably, some, like speech issues, may require additional support. It’s advisable to assess the patient’s response to the initial treatment before considering further interventions. Through this innovative therapy, stroke survivors can achieve enhanced motor skills, improved speech, and better memory retention, leading to a more independent and fulfilling life post-stroke.

Intrathecal Administrations for Post Stroke

Intrathecal administration involves delivering 35 to 100 million stem cells directly into the spinal fluid through a lumbar puncture performed by a board-certified anesthesiologist.

This method allows stem cells to bypass the blood-brain barrier and reach the brain, where they can penetrate and repair damaged neural tissue. The primary purpose of intrathecal administration is to repair and regenerate damaged neural and myelin sheath tissue, which makes up 98% of the brain. In the case of hemorrhagic strokes, it also targets the repair of blood vessel damage.

Additionally, this method aims to reduce brain and central nervous system inflammation in both the short and long term, which prepares damaged areas for regeneration and alleviates physical pressure within the brain.

Importantly, stem cells can replicate themselves, creating more exosomes that contribute to a longer-term healing cascade. Mobility considerations are essential for stroke patients during and after the procedure, particularly for overweight individuals who may require special care.

IV Administration

The intravenous (IV) treatment consists of administering 75 to 150 million stem cells and 3 to 5 billion exosomes.

The primary purpose of IV administration is to address the effects of stroke on the central nervous system (CNS) while also targeting peripheral nerves and the gut, often referred to as the “second brain.” The systemic delivery of stem cells and exosomes helps repair and regenerate potential nerve damage throughout the body, potentially reversing structural damage caused by strokes and alleviating associated symptoms. Moreover, the systemic anti-inflammatory effects of stem cells can provide a wide range of benefits.

The secondary purpose of IV treatment is to assist the patient’s other organs and internal systems, which often work harder to compensate for the reduced capacity caused by the primary condition. This treatment can help regenerate and repair damage to these secondary organs and muscles, as well as alleviate the strain on the kidneys and liver caused by processing various medications.

Stem Cells Specialists

Our team at CRC is committed to slowing the progression of neurodegenerative diseases through innovative regenerative treatments. Whether you are facing Parkinson’s, Alzheimer’s, or another neurodegenerative condition, our therapies are designed to support neural regeneration and enhance cognitive function. By targeting the brain’s natural healing mechanisms, we strive to improve your quality of life and preserve independence as long as possible.

Dr. Jorge Tagle, M.D.

Leading Stem Cells expert

One of the most prestigious specialists in Aesthetic procedures and Cosmetic Surgery in Tijuana, Mexico.
Owner of the ITC (Cell Therapy Institute), the biggest and most important Cell Banks in Mexico. He has treated Pro-Athletes and important politicians.

Mario Adolfo Cota Hermosillo, M.D.

Dr. Cota has focused on regenerative medicine since 2021, with extensive experience in applying stem cells in clinical practice. Currently pursuing a Master’s in Regenerative Medicine, he is already contributing to patient treatment and outcomes. His background in Anesthesiology provides a deep understanding of pain management, further enhancing his impact on patient care.

Google Reviews

1 Step 1
Rate UsDrop a Review Here
keyboard_arrow_leftPrevious
Nextkeyboard_arrow_right
FormCraft - WordPress form builder